+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Is postexposure prophylaxis with antiretroviral therapy necessary in cases of blood exposure through a fight when HIV-1 status is unknown?



Is postexposure prophylaxis with antiretroviral therapy necessary in cases of blood exposure through a fight when HIV-1 status is unknown?



Aids 28(1): 137-139




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053996972

Download citation: RISBibTeXText

PMID: 24413265

DOI: 10.1097/qad.0000000000000028


Related references

New guidelines for antiretroviral therapy in nonoccupational postexposure prophylaxis. Aids Clinical Care 17(3): 22, 2005

Announcement: Updated Guidelines for Antiretroviral Postexposure Prophylaxis after Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV - United States, 2016. Mmwr. Morbidity and Mortality Weekly Report 65(17): 458-458, 2016

Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services. Mmwr. Recommendations and Reports 54(Rr-2): 1-20, 2005

HIV medical providers' perceptions of the use of antiretroviral therapy as nonoccupational postexposure prophylaxis in 2 major metropolitan areas. Journal of Acquired Immune Deficiency Syndromes 64(Suppl. 1): S68-S79, 2013

HIV postexposure prophylaxis after blood exposure in school. Nasnewsletter 14(4): 17, 1999

Update on emerging infections: news from the Centers for Disease Control and Prevention. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States. Annals of Emergency Medicine 46(1): 82-86, 2005

Profile of occupational exposures to bloodborne pathogens and a 2-year experience of postexposure antiretroviral prophylaxis for occupational exposure to HIV among HCWs in Rio de Janeiro City, Brazil. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 39: 604, 1999

Brief report: effect of antiretroviral agents on T-lymphocyte subset counts in healthy HIV-negative individuals. The Italian Registry on Antiretroviral Postexposure Prophylaxis. Journal of Acquired Immune Deficiency Syndromes 24(5): 440-443, 2000

Postexposure prophylaxis, preexposure prophylaxis or universal test and treat: the strategic use of antiretroviral drugs to prevent HIV acquisition and transmission. Aids 24(Suppl. 4): S27-S39, 2010

Emergency department blood or body fluid exposure evaluations and HIV postexposure prophylaxis usage. Academic Emergency Medicine 10(12): 1345-1353, 2003

Blood and body fluid exposure and postexposure prophylaxis among health care workers at an urban medical center. Journal of Investigative Medicine 47(2): 137A, 1999

HIV antiretroviral postexposure prophylaxis: a cautionary note. Clinical Infectious Diseases 41(10): 1514-1516, 2005

Candidate antiretroviral agents for use in postexposure prophylaxis. American Journal of Medicine 102(5b): 25-31, 1997

Tolerability of postexposure antiretroviral prophylaxis for occupational exposures to HIV. Drug Safety 24(8): 587-597, 2001